Medicare Enrolled
Dr. Thuy Le, M.D.
Hematology & Oncology · Plano, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Le from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Le? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Le
Dr. Thuy Le is a hematology & oncology in Plano, TX, with 19 years in practice. Based on federal Medicare data, Dr. Le performed 85,813 Medicare services across 2,885 unique beneficiaries.
Between the years covered by Open Payments, Dr. Le received a total of $16,393 from 75 pharmaceutical and/or device companies across 477 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Le is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 10% volume in TX$ $16,393 industry payments
Medicare Practice Summary
Medicare Utilization ↗85,813
Medicare services
Top 10% in TX for hematology & oncology
2,885
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,516 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 30,300 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) | 21,600 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 19,800 | $41 | $137 |
| Dexamethasone injection (steroid) | 3,458 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,490 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 1,020 | $0 | $24 |
| Blood draw (venipuncture) | 1,014 | $8 | $20 |
| Complete blood count (CBC) with differential | 936 | $8 | $36 |
| Injection, fluorouracil, 500 mg | 710 | $2 | $13 |
| Comprehensive metabolic blood panel | 678 | $10 | $64 |
| Injection of additional new drug or substance into vein | 506 | $12 | $108 |
| Administration of chemotherapy into vein, 1 hour or less | 442 | $97 | $707 |
| Office visit, established patient (20-29 min) | 399 | $62 | $250 |
| Office visit, established patient (30-39 min) | 362 | $92 | $368 |
| Ferritin level test (iron stores) | 194 | $13 | $60 |
| Iron level test | 190 | $6 | $27 |
| Iron binding capacity test | 190 | $9 | $35 |
| Drug injection, under skin or into muscle | 188 | $11 | $96 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 162 | $22 | $157 |
| Administration of additional new drug or substance into vein, 1 hour or less | 159 | $49 | $344 |
| Injection, diphenhydramine hcl, up to 50 mg | 156 | $1 | $7 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 153 | $89 | $657 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 140 | $46 | $313 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 139 | $1,102 | $4,802 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 133 | $20 | $128 |
| Carcinoembryonic antigen (cea) protein level | 126 | $19 | $99 |
| Administration of chemotherapy into vein, each additional hour | 114 | $21 | $161 |
| Unclassified drugs | 101 | $1 | $8 |
| Injection of drug or substance into vein | 98 | $28 | $247 |
| Infusion, normal saline solution , 1000 cc | 97 | $2 | $19 |
| Microscopic examination for white blood cells with manual cell count | 83 | $4 | $22 |
| Complete blood count (CBC), automated | 83 | $6 | $34 |
| Administration of additional new drug or substance into vein using push technique | 82 | $42 | $289 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 80 | $15 | $94 |
| Reticulated (young) platelet measurement | 73 | $35 | $143 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 72 | $124 | $500 |
| Hospital follow-up visit, moderate complexity | 70 | $60 | $247 |
| New patient office visit (30-44 min) | 58 | $77 | $372 |
| New patient office visit (45-59 min) | 38 | $124 | $565 |
| Infusion into a vein for hydration, each additional hour | 34 | $9 | $75 |
| Office visit, established patient, complex (40-54 min) | 21 | $137 | $496 |
| Lactate dehydrogenase (enzyme) level | 19 | $6 | $31 |
| Infusion into a vein for hydration, 31-60 minutes | 17 | $25 | $256 |
| New patient office visit, complex (60-74 min) | 15 | $168 | $709 |
| Office visit, established patient (10-19 min) | 13 | $40 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
93.3% medium
6.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,393
Total received (2018-2024)
Avg $2,342/year across 7 years
Top 23% in TX for hematology & oncology
75
Companies
477
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,891 (66.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,507 (27.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$995 (6.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,499
2023$5,219
2022$2,188
2021$2,423
2020$354
2019$455
2018$257
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$2,344
Gilead Sciences, Inc.
$1,958
Baxter Healthcare
$1,395
Novartis Pharmaceuticals Corporation
$861
Janssen Scientific Affairs, LLC
$758
Merck Sharp & Dohme LLC
$563
Astellas Pharma US Inc
$560
Daiichi Sankyo Inc.
$556
AstraZeneca Pharmaceuticals LP
$454
Janssen Biotech, Inc.
$440
PFIZER INC.
$432
E.R. Squibb & Sons, L.L.C.
$395
Incyte Corporation
$395
Seagen Inc.
$302
Takeda Pharmaceuticals U.S.A., Inc.
$296
GENZYME CORPORATION
$193
Genentech USA, Inc.
$191
Puma Biotechnology, Inc.
$190
Epizyme, Inc.,
$186
Eisai Inc.
$185
SOBI, INC
$183
Kite Pharma, Inc.
$175
ABBVIE INC.
$165
PharmaEssentia USA Corporation
$156
Merck Sharp & Dohme Corporation
$154
Sirtex Medical Inc
$154
GlaxoSmithKline, LLC.
$150
Lilly USA, LLC
$139
Boehringer Ingelheim Pharmaceuticals, Inc.
$139
ARRAY BIOPHARMA INC
$135
Kyowa Kirin, Inc.
$131
Rigel Pharmaceuticals, Inc.
$112
Pharmacyclics LLC, An AbbVie Company
$111
Bayer Healthcare Pharmaceuticals Inc.
$107
Celgene Corporation
$89
Stemline Therapeutics Inc.
$80
Amgen Inc.
$80
Seattle Genetics, Inc.
$77
AVEO Pharmaceuticals, Inc.
$76
Adaptive Biotechnologies Corporation
$73
Apellis Pharmaceuticals, Inc.
$71
CTI BioPharma Corp.
$69
Mirati Therapeutics, Inc.
$64
Jazz Pharmaceuticals Inc.
$64
JAZZ PHARMACEUTICALS INC.
$63
Regeneron Healthcare Solutions, Inc.
$63
Myriad Genetic Laboratories, Inc.
$63
Karyopharm Therapeutics Inc.
$52
Aveo Pharmaceuticals, Inc.
$49
Sobi, Inc
$49
Ipsen Biopharmaceuticals, Inc
$46
Blueprint Medicines Corporation
$43
SERVIER PHARMACEUTICALS LLC
$42
PUMA BIOTECHNOLOGY, INC.
$41
ADC Therapeutics America, Inc.
$41
Exelixis Inc.
$39
Immunocore Limited
$34
Dendreon Pharmaceuticals LLC
$31
Acrotech Biopharma LLC
$27
Genmab U.S., Inc.
$27
GE HealthCare
$27
Pharmacyclics LLC, an AbbVie Company
$25
BeiGene USA, Inc.
$23
Masimo Corporation
$20
AbbVie Inc.
$20
PORTOLA PHARMACEUTICALS, INC.
$19
Acrotech Biopharma Inc.
$19
Foundation Medicine, Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$18
MENARINI SILICON BIOSYSTEMS, INC.
$17
EISAI INC.
$16
SpringWorks Therapeutics, Inc.
$15
Cumberland Pharmaceuticals, Inc.
$14
TAIHO ONCOLOGY, INC.
$14
Janssen Pharmaceuticals, Inc
$7
Top 3 companies account for 34.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · ANDEXXA · AYVAKIT · Abraxane · Alecensa · Asparlas · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CARVYKTI · CREON · CYRAMZA · Cabometyx · Cellsearch · Cresemba · DARZALEX · DOPTELET · ELAHERE · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Itovebi · JAKAFI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIVTENCITY · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nerlynx · Nplate · OGSIVEO · OJJAARA · OPDIVO · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Patient SafetyNet Console · Phesgo · Polivy · Pomalyst · Poteligeo · PreciseTumor · RYBREVANT · Rezlidhia · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SPRYCEL · SYLVANT · Stivarga · TABRECTA · TAGRISSO · TAZVERIK · TECVAYLI · TEPMETKO · TUKYSA · Tavalisse · Tecentriq · Trodelvy · VENCLEXTA · VERZENIO · VONJO · Vonjo · Voranigo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xospata · Xtandi · YERVOY · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (66%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $19 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
129
Per 100K population
11.6
County median income
$117,588
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Le is a mixed practice specialist, with above-average Medicare volume (top 10% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Le experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Le performed 30,300 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Le receive payments from pharmaceutical companies?
Yes. Dr. Le received a total of $16,393 from 75 companies across 477 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Le's costs compare to other hematology & oncologys in Plano?
Dr. Le's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Le) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Plano
Browse hematology & oncologys in Plano ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc..
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc..
By company
Baxter Healthcare Payments to Doctors
See all physicians who received payments from Baxter Healthcare.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology